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Abstract 
Purpose: To demonstrate the effectiveness of Centella asiatica aqueous extract in augmenting the 
cytotoxic effect of bleomycin in the adenocarcinoma human alveolar basal epithelial A549 cell line. 
Methods: The inhibitory effect of bleomycin on A549 cells was determined by incubating the cells for 24 
h in different concentrations of bleomycin. The effect of C. asiatica extract on A549 cells was 
determined after exposing cells to 5, 10, 15, 20, 25, and 30 % (v/v) bleomycin diluted from an initial 10% 
stock solution. Based on the 50 % inhibitory (IC50) values of bleomycin, 80, 100, and 120 µg/mL 
concentrations were tested with 15, 20, and 25 % (v/v) of C. asiatica extract. 
Results: IC50 value of bleomycin on A549 cells was 100 µg/mL, and was reduced to 80 µg/mL when 
cells were co-incubated with 20 % v/v of C. asiatica extract. The results show that C. asiatica extract 
reduces the concentration of bleomycin necessary for inhibition of A459 cell growth (IC50). While the 
IC50 value of bleomycin was 100 µg/ml, it fell to 80 µg/ml when used along with 20 % v/v CA extract (p < 
5) 
Conclusions: This study demonstrates that compounds extracted from C. asiatica may have potential 
for use as adjuvants in bleomycin cancer chemotherapy.  
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Phytochemicals are plant products used in 
traditional medicine. Several currently used 
therapeutic drugs are based on phytochemicals. 
Although plant products have been used for 
several centuries, the exact mechanisms by 
which these compounds function remain 
unknown, and further evidence-based dose 
effects of the phytochemicals are required.  
 
Centella asiatica is a herb of Asian origin 
belonging to the Apiaceae family and the 
Mackinlayoideae subfamily, also commonly 
known as the “gotu kola” or “centella.” Grown in 
wet areas; the leaves of this herb are commonly 
used in a variety of ways, ranging from preparing 
juices to porridges and salads. The medicinal 
uses of C. asiatica are well documented in a 
review by Kashmira et al [1]. Plant extracts of C. 
asiatica have been widely used to treat skin 
diseases, varicose veins, to reduce hypertension, 
to improve memory, and for wound healing. Its 
major use is as a brain tonic for improving 
nervous function [1].  
 
The extracts from the leaves and tender stems of 
C. asiatica confer beneficial effects from 
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compounds including triterpenoids, saponins, 
sapogenins, brahmoside, brahminoside, 
isothankuniside, thankuniside, sterols, 
flavanoids, indocentelloside, asiaticoside, and 
tannins. The two most active ingredients are 
bacoside A and bacoside B. Apart from their 
wound healing properties the triterpenoid 
compounds from C. asiatica exert beneficial 
effects primarily on the circulatory and the 
nervous systems. A comprehensive study of the 
herb, its natural compounds, the beneficial health 
effects, and pharmacological aspects of C. 
asiatica are available online from Examine.com, 
a portal that provides detailed evidence-based, 
scientific information on food supplements [2]. 
 
Cancers are a major global human health care 
concern with the types and incidence levels 
increasing at a significant rate. Cancers are 
complex diseases making them a challenge to 
understand, manage, and treat. This makes it 
very important to treat cancer using combinations 
of approaches. Targeted therapy, gene therapy, 
and rendering cancer cells more susceptible to 
therapeutic drugs are currently in use. While the 
discovery of new drugs is critical, enhancing the 
effects of currently available chemotherapeutic 
drugs can also be useful. Modulators that 
enhance the effectiveness of radiotherapy and 
chemotherapy can be used as adjuvants and 
offer several advantages [3].  
 
In this regard, the use of pulsed electromagnetic 
field treatments includes studies with 
radiotherapy [4] as well as with 
chemotherapeutic drugs [5]. Other well-studied 
modulators for cancer therapy include antibodies 
used as immunostimulatory agents [6], metal 
compounds such as arsenic trioxide [7], statins 
such as simvastatin [8], isoflavones from soy [9], 
prostaglandin inhibitors [10], and nanoparticles 
[11].  
 
Established and well-characterized cancer cell 
lines are widely used for cancer research. There 
are many cancer cell lines currently available for 
research purposes. These continuous cell lines 
offer unique advantages as model systems. 
A549 is an adenocarcinoma human alveolar 
basal epithelial cell line. Bleomycin is a widely 
used cancer chemotherapeutic drug and several 
in vitro studies have shown the usefulness of 
bleomycin (a radiomimetic drug) on cancer cell 
lines used as models for cancer research. The 
effects of bleomycin on lung epithelial cells are 
well-known [12–14]. Bleomycin was also used to 
study the modulatory effects of caveolin-1 on 
apoptosis and senescence in lung cells, making 
this model a reliable choice to determine the 
modulatory or synergistic effects of supplements 
[15]. 
 
We determined the possible augmentative 
effects of C. asiatica leaf extract on the 
anticancer cytotoxic effects of bleomycin in A549 
cells. The role of C. asiatica in radioprotection of 
A549 cells has been previously studied. An 
active ingredient of C. asiatica, asiatic acid, was 
shown to have inhibitory effects on A549 cell 
growth [16]. The documented applications of C. 
asiatica in radioprotection or during radiotherapy 
also include advantageous psychological effects 
such as positive behavioural changes [17]. C. 
asiatica extracts were also shown to be 
advantageous (at 100 mg/kg body weight) in 
increasing the survival and minimizing body 
weight loss in Swiss albino mice exposed to 
Cobalt-60 (60Co) gamma radiation at a sublethal 
dose of 8 Gy [18]. 
 
In this study, we assessed the potential use of C. 
asiatica for cancer therapy as a supplement or as 
an adjunctive agent. Treatments which increase 
the sensitivity of cancer cells to a therapeutic 
drug can result in a decreasing dose, thereby 
avoiding some of the side effects of such drugs 
on normal cells and tissues. Further studies 
should determine the usefulness of commonly 
available phytochemicals as augmentative 




C. asiatica were collected from a natural habitat 
with no apparent pollution and the stems along 
with the leaves were harvested, cleaned three 
times with sterile distilled water, and then with 
phosphate-buffered saline (PBS). The leaves 
and tender stems were dried in an oven for 84 h 
at 45 °C and were then milled to obtain a 
powder. The aqueous extract was obtained from 
this powder by adding 100 mL of distilled water 
to every 10 g of the plant powder to obtain a 10 
% w/v concentration of the final extract. The 
mixture was incubated at 4 °C for 1 h, refluxed, 
vacuum filtered, and then sterilized using 0.4 
micron filters followed by a 0.2 micron filter. Ten 
grams of the plant powder was extracted using 
100 mL of distilled water to obtain a final 
concentration of 10 % v/v. Aliquots of the extract 
(CA extract) were stored at 4 °C and various 
concentrations were obtained using the 10 % 
stock solution.  
 
The A549 cells obtained from American Type 
Culture Collection (ATCC), USA were maintained 
in Dulbecco’s Minimum Essential Medium 
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(DMEM) obtained from Gibco BRL, USA 
supplemented with 10 % fetal bovine serum in T-
24 flasks, and were passaged when they 
reached 90 % confluency. The A549 cells were 
cultured in 12-well plates to determine the IC50 
values of bleomycin and the effects of CA 
extracts. Triplicate cultures in 12-well plates were 
used for each concentration of bleomycin, CA 
extract, and the combinations of bleomycin and 
CA extract. The seeding density for all 
experiments was 0.16 × 106 cells per well and 
cells were > 97 % viable, and at 50 % 
confluency.  
 
The doses used to determine the IC50 value of 
bleomycin-induced cytotoxicity on A549 cells 
were 20, 40, 60, 80, 100, 120, 140, 160, 180, 
and 200 µg/mL. Cells were incubated for 24 h, 
the monolayers were washed three times with 
sterile PBS, trypsinized, and cell viability was 
calculated using trypan blue dye exclusion.  
 
The doses of the CA extract used to study its 
effects on the A549 cells were 5, 10, 15, 20, 25, 
and 30 % (v/v) from the stock 10 % solution. 
Cells were incubated for 24 h with the CA extract 
and the viability was calculated. Based on the 
IC50 values of bleomycin and the effects of CA 
extracts on the A549 cells,  bleomycin was used 
at 80, 100, and 120 µg/mL, and each of these 
concentrations were tested with 15, 20, and 25 % 
(v/v) of CA extract, in triplicate to ascertain the 
modulatory effects of CA extract on bleomycin 
inhibitory activity. Cells were incubated in the 
bleomycin-CA extract combinations for 24 h and 




The percent cytotoxicity at various levels of 
bleomycin was determined, and the IC50 was 
determined as the concentration of the drug 
which induced killing of 50 % of the cell 
population. Samples were in triplicate and results 
are expressed as mean ± SD. Statistical analysis 
included the percent cytotoxicity and the 
maximum percent toxicity. The association of the 
cytotoxic drug individually and in combination 
with the phytochemical extract was shown by 




In total, 100 mL of the CA aqueous extract was  
obtained and was stored as aliquots at 4 °C. 
There was a dose-dependent increase on the 
cytotoxic effect of bleomycin on A549 cells with 
an IC50 value of approximately 100 µg/mL 
(Figure 1). 
 
Of the six concentrations of the CA leaf extract 
used, the 5, 10, 15, and 20 % (v/v) 
concentrations did not have any effects on the 
A549 cells. However, the cells exposed to 25 % 
and 30 % (v/v) CA extract showed cell 
granulation and debris in the culture medium 
(Figure 2). 
 
The optimal concentration of CA extract was 20 
% (v/v) for bleomycin IC50 of 80 µg/mL. 
Combinations of bleomycin with 15 and 25 % 
(v/v) CA extracts did not provide enhancement 
when compared to cells exposed to 100 or 120 
µg/mL bleomycin alone. In summary, 
supplementation with 20 % (v/v) CA extract 
provided significant enhancement of bleomycin 




C. asiatica is well documented in the scientific 
literature for its beneficial human healthcare 
effects. Although its applications for various 
indications such as neurological disorders, 
vascular disorders, and wound healing are well 
documented, it was of interest to determine if it 
has synergistic action on commonly used 
therapeutic drugs. Bleomycin is a radiomimetic 
cancer chemotherapeutic drug widely used with 
cell cultures in vitro to study therapeutics. 
 
A549 cells exposed to bleomycin for 24 h 
exhibited an IC50 of 100 µg/mL. Exposure to CA 
extracts did not have apparent effects, although 
the cells had aberrant morphology when 
supplemented with 25 % and 30 % (v/v) CA. This 
might be due to the changes in the medium 
characteristics and composition when 
supplemented with the additional volumes from 
the given extract. Three concentrations of 
bleomycin were used for combination 
experiments based on the IC50 value of 
bleomycin on the A549 cells. In addition, three 
concentrations of the CA extract that did not 
cause aberrant cell morphology were used for 
the combination exposure studies. While 15 % 
and 25 % (v/v) of CA extract did not show 
modulatory effects alone, the 20 % (v/v) CA 
enhanced the inhibitory effect of bleomycin on 
the A549 cells. The IC50 of 100 µg/mL bleomycin 
alone was reduced to 80 µg/mL when cells were 
supplemented   with  20 %  (v/v)  CA   extract. In. 
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Figure 1: Panel A. Bleomycin induced dose-dependent cytotoxicity on A549 cells when given for 24 h. The IC50 
value of bleomycin was 100 µg/mL. Panel B. A549 cells incubated with 80, 100, and 120 µg/mL bleomycin 
combined with 15, 20, and 25 % (v/v) CA extract demonstrated that the combination of 80 µg/mL bleomycin and 
20 % (v/v) CA extract gave a synergistic enhancement of the inhibitory effects of bleomycin. This combination 
resulted in a reduction of the IC50 value of bleomycin to 80 µg/mL, compared to 100 µg/mL with bleomycin alone. 
However, there was no significant change in the IC50 values in cultures with a combination with either 15 % or 25 




Figure 2: (A) A549 cells exposed to 5, 10, 15, and 20 % (v/v) from the 10 % initial stock solution of CA extract 
did not exhibit any morphological changes; however, the cultures exposed to 25 % and 30 % (v/v) CA extract 
from the initial 10 % stock solution of CA extract did show morphological changes (B) and (C), perhaps due to 
increased culture volumes from the CA extracts. Cell morphology was markedly altered as seen in panel 3 with 
less adhered spindle-shaped healthy cells. Also, granulation and debri were seen to increase in cultures 
supplemented with 30 % (v/v) CA extract 
 
summary, our study demonstrates synergistic 
and modulatory effects of CA extract, and 
suggests the importance of choosing the correct 
combination doses for maximizing the 




Phytochemicals have been in use in human 
health care for several centuries. However, 
additional data are required for their acceptance 
and wide utilization. C. asiatica is well 
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documented for its human health care 
applications and its mechanisms of action have 
been studied. The findings of this study indicate 
the usefulness of C. asiatica as an adjuvant for 
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